Validus Cellular Therapeutics, Inc. — Form D
Validus Cellular Therapeutics, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-11. The offering totals $2.0M, of which $25K was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-01-11
- Form: D
- Accession: 0001820379-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $25K
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2021-11-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-428819
Issuer
- Name: Validus Cellular Therapeutics, Inc.
- CIK: 0001820379
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12635 E MONTVIEW BLVD., AURORA, CO, 80045
- Phone: 720-767-0350
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Steven Dow | Director | Aurora, CO |
| Frank Barry | Director | Los Angeles, CA |
| Ethan Mann | Director | Aurora, CO |
| Ethan Mann | Executive Officer | Aurora, CO |
| Mike Handley | Director | Aurora, CO |
Other filings by this issuer (2)
More